Demetrix

Berkeley, United States Founded: 2017 • Age: 9 yrs
Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology.
Annual revenue - Latest available
Total funding $61.0M 2 rounds
Employees 77 Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Demetrix

Demetrix is a company based in Berkeley (United States) founded in 2017 by William A Haseltine and Jay Keasling. Demetrix has raised $61 million across 2 funding rounds from investors including Tuatara Capital, Horizons Ventures and Li Ka-shing. The company has 77 employees as of December 31, 2022. Demetrix operates in a competitive market with competitors including Vireo Health, Nutritional High, Alphargreen Group Limited, DEMECAN and Shopbeam, among others.

  • Headquarter Berkeley, United States
  • Employees 77 as on 31 Dec, 2022
  • Founders William A Haseltine, Jay Keasling
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Demetrix, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $61 M (USD)

    in 2 rounds

  • Latest Funding Round
    $50 M (USD), Series A

    Jul 11, 2019

  • Investors
  • Employee Count
    77

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Demetrix

Headcount 10-50
Employee Profiles 2
Board Members and Advisors 4
Board Members and Advisors
people
William Haseltine
Director
people
Jay Keasling
Director
people
Marc Riiska
Director
people
Patrick Zhang
Director

Unlock access to complete

Funding Insights of Demetrix

Demetrix has successfully raised a total of $61M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $50 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Demetrix

Demetrix has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Tuatara Capital, Horizons Ventures and Li Ka-shing.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Horizons Ventures is focused on investing in deep science and technology.
Locked Locked Locked
Private equity firm investing and cannabis-focused consumer and retail firms
Locked Locked Locked

Li Ka-shing

-
Locked Locked Locked
Premium access

Investor details for Demetrix

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Demetrix

Investments
Premium access

Investment portfolio details for Demetrix

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Demetrix

Premium access

Detailed financials for Demetrix

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Demetrix Comparisons

Demetrix Primary company
Description
Cannabinoid ingredients for pharmaceuticals are produced via...
Location
Berkeley, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
77
As of 2022
Premium access

Peer comparison for Demetrix

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Demetrix

Demetrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vireo Health, Nutritional High, Alphargreen Group Limited, DEMECAN and Shopbeam, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cannabis plants are cultivated in greenhouses for wellness product development.
Locked Locked Locked
Cannabis-infused products are developed, manufactured, and distributed for consumers.
Locked Locked Locked
Online marketplace for cannabis products treating various diseases is operated.
Locked Locked Locked
Producer of medical cannabis
Locked Locked Locked
Provider of fine art photography prints and books
Premium access

Detailed competitors of Demetrix

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Demetrix

Premium access

Complete news archive for Demetrix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Demetrix

Demetrix was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Demetrix is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

Jeff Ubersax is the current CEO of Demetrix.

Demetrix is a funded company, having raised a total of $61M across 2 funding rounds to date.

As of Dec 31, 2022, the latest employee count at Demetrix is 77.

Demetrix was founded in 2017 in Berkeley, United States, and operates within the biotechnology sector focused on cannabinoids. Rare, high-purity cannabinoid ingredients are developed and commercialized using fermentation technology for pharmaceutical and consumer health applications. Production processes are regulated to ensure compliance, with emphasis placed on wellness products derived from these ingredients. Operations are centered in the United States, supporting global commercialization efforts.

Demetrix's top competitors include Vireo Health, Alphargreen Group Limited and Nutritional High.

Demetrix has 3 investors. Key investors include Tuatara Capital, Horizons Ventures, and Li Ka-shing.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available